Canadian Association of Veterinary Cannabinoid Medicine

Canadian Association of Veterinary Cannabinoid Medicine

The core objectives of the Canadian Association of Veterinary Cannabinoid Medicine are to help guide legislative changes that would ensure veterinarians have fair access to appropriate cannabis products (quality and quantity assurances) for veterinary medical use. Collaborate with groups conducting species specific cannabis-based studies on the safety, dosing, and indications of cannabinoid veterinary medicines. Collect, evaluate, and disseminate information surrounding the appropriate use of medical cannabis in veterinary patients through education of veterinary professionals and general public.
Education
Medical Resources

About Canadian Association of Veterinary Cannabinoid Medicine

Here at the Canadian Association of Veterinary Cannabinoid Medicine, we are driven by our motivation to improve our understanding of cannabis-based therapies for animals, and to improve our clients' ability to access these therapies.  Advocating for veterinary access to cannabis is an important part of our mission, and so we work closely with veterinary associations and engage Health Canada as new legislation is proposed.  We work hard to bring information to both the veterinary profession and pet families, and we encourage species-specific research in this area, and work collaboratively with groups undertaking this research. We continually strive to provide animals with an improved quality of life through evidence-based application of cannabinoid therapy.

We are a national non-profit corporation founded by a group of veterinary professionals. The association is overseen by a board of directors, and managed by a group of officers, that ensure we continue to work towards a common goal.  Membership with voting rights, is open to all veterinary professionals, including both veterinarians and registered veterinary technicians.  We also welcome other scientists working within the cannabis industry, including researchers, physiologists, and biochemists, as well as interested industry groups, to join our association as supporters so that we may continue to share ideas and further education about the endocannabinoid system and the possibilities for therapies targeted to this area.

Team

CORNELIA MOSLEY
Director and Vice-President
JAIME BRASSARD
Director
KAROL MATHEWS
Director
KATHERINE KRAMER
Director

Participation in events